These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

29 related articles for article (PubMed ID: 8504474)

  • 1. A monoclonal antibody against p53 cross-reacts with processing bodies.
    Thomas MG; Luchelli L; Pascual M; Gottifredi V; Boccaccio GL
    PLoS One; 2012; 7(5):e36447. PubMed ID: 22590546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CCN5/WISP-2 restores ER-∝ in normal and neoplastic breast cells and sensitizes triple negative breast cancer cells to tamoxifen.
    Sarkar S; Ghosh A; Banerjee S; Maity G; Das A; Larson MA; Gupta V; Haque I; Tawfik O; Banerjee SK
    Oncogenesis; 2017 May; 6(5):e340. PubMed ID: 28530705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenome remodelling in breast cancer: insights from an early in vitro model of carcinogenesis.
    Locke WJ; Clark SJ
    Breast Cancer Res; 2012 Nov; 14(6):215. PubMed ID: 23168266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53 status and response to radiotherapy in rectal cancer: a prospective multilevel analysis.
    Lopez-Crapez E; Bibeau F; Thézenas S; Ychou M; Simony-Lafontaine J; Thirion A; Azria D; Grenier J; Senesse P
    Br J Cancer; 2005 Jun; 92(12):2114-21. PubMed ID: 15956964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Replication of an E1B 55-kilodalton protein-deficient adenovirus (ONYX-015) is restored by gain-of-function rather than loss-of-function p53 mutants.
    Hann B; Balmain A
    J Virol; 2003 Nov; 77(21):11588-95. PubMed ID: 14557644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estradiol stabilizes p53 protein in breast cancer cell line, MCF-7.
    Okumura N; Saji S; Eguchi H; Hayashi S; Saji S; Nakashima S
    Jpn J Cancer Res; 2002 Aug; 93(8):867-73. PubMed ID: 12716463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of p53 by metal ions and by antioxidants: dithiocarbamate down-regulates p53 DNA-binding activity by increasing the intracellular level of copper.
    Verhaegh GW; Richard MJ; Hainaut P
    Mol Cell Biol; 1997 Oct; 17(10):5699-706. PubMed ID: 9315628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA damage-inducible genes as biomarkers for exposures to environmental agents.
    Johnson NF; Carpenter TR; Jaramillo RJ; Liberati TA
    Environ Health Perspect; 1997 Jun; 105 Suppl 4(Suppl 4):913-8. PubMed ID: 9255580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclin E, a redundant cyclin in breast cancer.
    Gray-Bablin J; Zalvide J; Fox MP; Knickerbocker CJ; DeCaprio JA; Keyomarsi K
    Proc Natl Acad Sci U S A; 1996 Dec; 93(26):15215-20. PubMed ID: 8986790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defective interleukin six expression and responsiveness in human mammary cells transformed by an adeno 5/SV40 hybrid virus.
    Basolo F; Fiore L; Calvo S; Falcone V; Conaldi PG; Fontanini G; Caligo AM; Merlo G; Gluzman Y; Toniolo A
    Br J Cancer; 1996 Jun; 73(11):1356-61. PubMed ID: 8645579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutational analysis of human papillomavirus type 16 E6 demonstrates that p53 degradation is necessary for immortalization of mammary epithelial cells.
    Dalal S; Gao Q; Androphy EJ; Band V
    J Virol; 1996 Feb; 70(2):683-8. PubMed ID: 8551603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53-dependent and p53-independent activation of apoptosis in mammary epithelial cells reveals a survival function of EGF and insulin.
    Merlo GR; Basolo F; Fiore L; Duboc L; Hynes NE
    J Cell Biol; 1995 Mar; 128(6):1185-96. PubMed ID: 7896881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of p53 protein during radiation transformation of primary human mammary epithelial cells.
    Wazer DE; Chu Q; Liu XL; Gao Q; Safaii H; Band V
    Mol Cell Biol; 1994 Apr; 14(4):2468-78. PubMed ID: 7511207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and stability of p53 protein in normal human mammary epithelial cells.
    Delmolino L; Band H; Band V
    Carcinogenesis; 1993 May; 14(5):827-32. PubMed ID: 8504474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor cell-specific loss of p53 protein in a unique in vitro model of human breast tumor progression.
    Liu XL; Band H; Gao Q; Wazer DE; Chu Q; Band V
    Carcinogenesis; 1994 Sep; 15(9):1969-73. PubMed ID: 7923592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53 mutations in human immortalized epithelial cell lines.
    Lehman TA; Modali R; Boukamp P; Stanek J; Bennett WP; Welsh JA; Metcalf RA; Stampfer MR; Fusenig N; Rogan EM
    Carcinogenesis; 1993 May; 14(5):833-9. PubMed ID: 8504475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutant p53-induced immortalization of primary human mammary epithelial cells.
    Gao Q; Hauser SH; Liu XL; Wazer DE; Madoc-Jones H; Band V
    Cancer Res; 1996 Jul; 56(13):3129-33. PubMed ID: 8674072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations in p53 are frequent in the preneoplastic stage of mouse mammary tumor development.
    Jerry DJ; Ozbun MA; Kittrell FS; Lane DP; Medina D; Butel JS
    Cancer Res; 1993 Jul; 53(14):3374-81. PubMed ID: 8324748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of retinoblastoma and p53 tumor suppressor pathways in human mammary epithelial cell immortalization.
    Band V
    Int J Oncol; 1998 Mar; 12(3):499-507. PubMed ID: 9472085
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.